| pubmed-article:20416126 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20416126 | lifeskim:mentions | umls-concept:C0001554 | lld:lifeskim |
| pubmed-article:20416126 | lifeskim:mentions | umls-concept:C0054871 | lld:lifeskim |
| pubmed-article:20416126 | lifeskim:mentions | umls-concept:C0441655 | lld:lifeskim |
| pubmed-article:20416126 | lifeskim:mentions | umls-concept:C0015648 | lld:lifeskim |
| pubmed-article:20416126 | lifeskim:mentions | umls-concept:C0597304 | lld:lifeskim |
| pubmed-article:20416126 | lifeskim:mentions | umls-concept:C0392756 | lld:lifeskim |
| pubmed-article:20416126 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:20416126 | pubmed:dateCreated | 2011-1-28 | lld:pubmed |
| pubmed-article:20416126 | pubmed:abstractText | The objective of this study was to assess the proteolytic activity of Fasciola hepatica cathepsins in liver sections from mice vaccinated with phage clones of cathepsin L mimotopes, using the film in situ zymography technique. Female BALB/c mice were immunized three times with 2.5 x 10¹¹ phage particles without adjuvant. Animals vaccinated with phage clones produced high titres of anti-mimotope antibodies and a significant reduction in fluke burden was observed following challenge with metacercariae of F. hepatica. The proteolytic activity in hepatic tissue was reduced after the immunization with phage clones. | lld:pubmed |
| pubmed-article:20416126 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20416126 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20416126 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20416126 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20416126 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20416126 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20416126 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20416126 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20416126 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20416126 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:20416126 | pubmed:issn | 1475-2697 | lld:pubmed |
| pubmed-article:20416126 | pubmed:author | pubmed-author:AlonsoR ARA | lld:pubmed |
| pubmed-article:20416126 | pubmed:author | pubmed-author:Quiroz-Romero... | lld:pubmed |
| pubmed-article:20416126 | pubmed:author | pubmed-author:CorreaDD | lld:pubmed |
| pubmed-article:20416126 | pubmed:author | pubmed-author:Villa-Mancera... | lld:pubmed |
| pubmed-article:20416126 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20416126 | pubmed:volume | 85 | lld:pubmed |
| pubmed-article:20416126 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20416126 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20416126 | pubmed:pagination | 51-5 | lld:pubmed |
| pubmed-article:20416126 | pubmed:meshHeading | pubmed-meshheading:20416126... | lld:pubmed |
| pubmed-article:20416126 | pubmed:meshHeading | pubmed-meshheading:20416126... | lld:pubmed |
| pubmed-article:20416126 | pubmed:meshHeading | pubmed-meshheading:20416126... | lld:pubmed |
| pubmed-article:20416126 | pubmed:meshHeading | pubmed-meshheading:20416126... | lld:pubmed |
| pubmed-article:20416126 | pubmed:meshHeading | pubmed-meshheading:20416126... | lld:pubmed |
| pubmed-article:20416126 | pubmed:meshHeading | pubmed-meshheading:20416126... | lld:pubmed |
| pubmed-article:20416126 | pubmed:meshHeading | pubmed-meshheading:20416126... | lld:pubmed |
| pubmed-article:20416126 | pubmed:meshHeading | pubmed-meshheading:20416126... | lld:pubmed |
| pubmed-article:20416126 | pubmed:meshHeading | pubmed-meshheading:20416126... | lld:pubmed |
| pubmed-article:20416126 | pubmed:meshHeading | pubmed-meshheading:20416126... | lld:pubmed |
| pubmed-article:20416126 | pubmed:meshHeading | pubmed-meshheading:20416126... | lld:pubmed |
| pubmed-article:20416126 | pubmed:meshHeading | pubmed-meshheading:20416126... | lld:pubmed |
| pubmed-article:20416126 | pubmed:meshHeading | pubmed-meshheading:20416126... | lld:pubmed |
| pubmed-article:20416126 | pubmed:meshHeading | pubmed-meshheading:20416126... | lld:pubmed |
| pubmed-article:20416126 | pubmed:meshHeading | pubmed-meshheading:20416126... | lld:pubmed |
| pubmed-article:20416126 | pubmed:meshHeading | pubmed-meshheading:20416126... | lld:pubmed |
| pubmed-article:20416126 | pubmed:meshHeading | pubmed-meshheading:20416126... | lld:pubmed |
| pubmed-article:20416126 | pubmed:meshHeading | pubmed-meshheading:20416126... | lld:pubmed |
| pubmed-article:20416126 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:20416126 | pubmed:articleTitle | Proteolytic activity in Fasciola hepatica is reduced by the administration of cathepsin L mimotopes. | lld:pubmed |
| pubmed-article:20416126 | pubmed:affiliation | Laboratorio de Genética y Reproducción, Facultad de Medicina Veterinaria y Zootecnia, Benemérita Universidad Autónoma de Puebla, 4 Sur 304 Col. Centro, C.P. 75482, Tecamachalco Puebla, México. abel.villa@gmail.com | lld:pubmed |
| pubmed-article:20416126 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20416126 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
